|
US6852721B2
(en)
|
2000-05-25 |
2005-02-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
US6624167B1
(en)
|
2000-08-04 |
2003-09-23 |
Targacept, Inc. |
Pharmaceutical compositions and methods for use
|
|
EP1231212B1
(en)
*
|
2001-02-06 |
2006-12-20 |
Pfizer Products Inc. |
Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders
|
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
|
SE0202430D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New Compounds
|
|
SE0202465D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
New compounds
|
|
SK288115B6
(sk)
|
2002-09-25 |
2013-09-03 |
Memory Pharmaceuticals Corporation |
Indazoles, pharmaceutical compositions comprising them and their use
|
|
EP1599476B1
(en)
*
|
2003-02-27 |
2009-10-14 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives
|
|
CN100445285C
(zh)
*
|
2003-12-22 |
2008-12-24 |
阿斯利康(瑞典)有限公司 |
烟碱性乙酰胆碱受体配体
|
|
TW200529860A
(en)
*
|
2003-12-22 |
2005-09-16 |
Astrazeneca Ab |
Nicotinic acetylcholine receptor ligands
|
|
WO2005063767A2
(en)
|
2003-12-22 |
2005-07-14 |
Memory Pharmaceuticals Corporation |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
|
|
EP1713810B1
(en)
*
|
2004-02-04 |
2010-12-29 |
NeuroSearch A/S |
Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
|
|
BRPI0508771A
(pt)
|
2004-03-25 |
2007-08-14 |
Memory Pharm Corp |
indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
|
|
EP1742944B1
(en)
|
2004-04-22 |
2010-11-10 |
Memory Pharmaceuticals Corporation |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
|
|
US7632831B2
(en)
*
|
2004-05-07 |
2009-12-15 |
Memory Pharmaceuticals Corporation |
1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
|
|
US7652010B2
(en)
|
2004-10-15 |
2010-01-26 |
Neurosearch A/S |
Azabicyclic aryl derivatives and their medical use
|
|
WO2006069097A2
(en)
|
2004-12-22 |
2006-06-29 |
Memory Pharmaceuticals Corporation |
Nicotinic alpha-7 receptor ligands and preparation and uses thereof
|
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
|
JP2009526776A
(ja)
*
|
2006-02-14 |
2009-07-23 |
ノイロサーチ アクティーゼルスカブ |
新規なジアザビシクロアルカン誘導体及びその医療上の使用
|
|
JP2007217370A
(ja)
*
|
2006-02-17 |
2007-08-30 |
Nard Inst Ltd |
ポジトロン断層撮影法および該方法に用いるポジトロン放出化合物
|
|
JP2009537598A
(ja)
|
2006-05-23 |
2009-10-29 |
ノイロサーチ アクティーゼルスカブ |
新規１，４−ジアザ−ビシクロ［３．２．２］ノナン誘導体及びそれらの医学的使用
|
|
US20100234349A1
(en)
|
2006-09-04 |
2010-09-16 |
Olsen Gunnar M |
Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
|
|
WO2008119710A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Neurosearch A/S |
Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
FR2931677B1
(fr)
*
|
2008-06-02 |
2010-08-20 |
Sanofi Aventis |
Association d'un agoniste partiel des recepteurs nicotiniques et d'un inhibiteur d'acetylcholinesterase, composition la contenant et son utilisation dans le traitement des troubles cognitifs
|
|
FR2931823B1
(fr)
|
2008-06-02 |
2012-08-17 |
Sanofi Aventis |
Sel de fumarate du 1,4-diazabicyclo°3.2.2!nonane-carboxylate de 4-bromophenyle, ses formes cristallines, leur preparation et leur utilisation en therapeutique
|
|
WO2010059844A1
(en)
|
2008-11-19 |
2010-05-27 |
Envivo Pharmaceuticals, Inc. |
Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
|
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
|
CN102802620A
(zh)
*
|
2009-05-11 |
2012-11-28 |
英维沃医药有限公司 |
使用某种α-7烟酸受体与乙酰胆碱酯酶抑制剂结合治疗认知障碍
|
|
PT3029039T
(pt)
|
2010-05-17 |
2017-11-28 |
Forum Pharmaceuticals Inc |
Formulações farmacêuticas que compreendem formas cristalinas de cloridrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida mono-hidratado
|
|
MX365245B
(es)
*
|
2011-03-18 |
2019-05-28 |
Genzyme Corp |
Inhibidores de glucosilceramida sintasa.
|
|
AU2013259871A1
(en)
|
2012-05-08 |
2014-11-20 |
Forum Pharmaceuticals Inc. |
Methods of maintaining, treating or improving cognitive function
|
|
MA37975B2
(fr)
|
2012-09-11 |
2021-03-31 |
Genzyme Corp |
Inhibiteurs de synthase de glucosylcéramide
|
|
MX2023001014A
(es)
|
2020-07-24 |
2023-03-01 |
Genzyme Corp |
Composiciones farmaceuticas que comprenden venglustat.
|
